openPR Logo
Press release

Big opportunity for Cancer Diagnostics Market Worldwide as patients affected with cancers of lung, breast, and colorectal Increases

01-12-2017 12:48 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Big opportunity for Cancer Diagnostics Market Worldwide as

The global cancer diagnostics market has been witnessing significant growth over the last couple of years due to the rising number of cancer incidences across the globe. The global cancer diagnostics market is likely to expand at an exponential rate owing to the favorable government regulations and increasing funding for cancer research projects. For the treatment and early detection of any kind of cancer, it is important to develop new cancer screening techniques. Treatments such as tumor biomarker tests, biopsy, endoscopy, and imaging collectively comprise the global market for cancer diagnostics.

Obtain the Upcoming Market Analysis of Cancer Diagnostics at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3637

According to a report published by Transparency Market Research, the global cancer diagnostics market is likely to expand at a 7.6% CAGR from 2014 to 2020. In 2013, the market was worth US$1, 00,994.5 mn and is projected to touch a valuation of US$1,68,649.3 mn by the end of 2020.

How will innovation turn out to be the backbone of the cancer diagnostics market?

Cancer diagnostics is really important for detecting cancer in the early stages and efficiently treating it. Thus, medical institutions and research bodies are investing in the development of advanced techniques and improving the existing ones to cater to the needs of patients. The demand for cancer diagnostics is likely to intensify over the next couple of years owing to the advent of breakthrough techniques for cancer detection such as transcriptomics, genomics, metabolomics, and proteomics. Although there have been significant developments in the technology of cancer diagnostics, the goal of achieving a reduced mortality rate has not been completely achieved.

However, researchers are focusing on developing advanced techniques. For instance, recently scientists from the Washington State University have introduced a method to detect cancer through an ELISA plate, a prism, and a smartphone. Scientists of the university declared the technique successful when they detected interleukin-6 with an accuracy of 99%.

What factors will hinder the growth of the global cancer diagnostics market?

The growth of the market for global cancer diagnostics is extensively dependent on the research and development activities and development of innovative products. In spite of the advent of advanced techniques, the market is likely to face challenges from certain factors such as low cost benefit ratio of biomarkers and high initial capital investments. The shortage of helium and expensive systems for diagnostic imaging are further expected to hinder the growth of the global cancer diagnostics market. The market will also be negatively affected by the dearth of experience and skilled workforce and risks of exposure to high radiation.

Read the Current Analysis for Cancer Diagnostics Market at: http://www.transparencymarketresearch.com/cancer-diagnostics-market.html

Towards what should vendors turn to gain lucrative opportunities?

Manufacturers of cancer diagnostic equipment can capitalize on the opportunities arising from the untapped market in emerging economies and the development of personalized medicine. Emerging markets are likely to be proved beneficial due to the improvement of healthcare infrastructure in these regions. Likewise, advances in miniature device technology and companion diagnostics are further expected to help manufacturers expand their consumer base.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Big opportunity for Cancer Diagnostics Market Worldwide as patients affected with cancers of lung, breast, and colorectal Increases here

News-ID: 411418 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For